Anomali Announces Major Expansion of Threat Platform Partner Ecosystem
New Developer SDKs enable partners to integrate solutions with Anomali Threat Platform
NATIONAL HARBOR, Md., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Anomali today announced at the Detect Conference 2018 the expansion of the partner ecosystem with the launch of a suite of partner developer resources. The new tools enable easier and faster integration with the Anomali Threat Platform and APP Store, allowing clients immediate access to partner content, integrations and analytics.
The partner program expansion includes the launch of a suite of software development kits (SDKs). The SDKs address three critical integration areas:
- Threat Intelligence Feeds SDK: integrate proprietary threat intelligence feeds and make these accessible via the APP Store
- Integration SDK: integrate threat intelligence from the Anomali Threat Platform into third party products and solutions
- Enrichment SDK: integrate 3rd party threat analysis and data enrichments into the Anomali Threat Platform
“Organizations need a comprehensive threat platform that incorporates the most relevant threat intelligence, integrates with their internal security stack, and leverages the most valuable analytics available,” said Hugh Njemanze, chief executive officer at Anomali. “We developed these SDKs to deliver better threat visibility and response. I’m grateful to our partners, Symantec, Intel471, and RiskIQ for their early adoption and feedback, and welcome all interested partners to work with Anomali.”
“We share Anomali’s commitment to enabling more seamless interoperability of our solutions to deliver the full promise of threat intelligence,” said Peter Doggart, vice president business development, Symantec. “The Anomali Integration SDK furthers this vision and we look forward to working with Anomali to combine the power of Symantec’s Integrated Cyber Defense Platform with their cyber threat intelligence.”
“Combatting sophisticated cybercriminals requires timely, relevant and actionable intelligence that can be operationalized easily within an organization”, said Michael Anderson, vice president of partnerships at Intel 471. “Anomali’s SDK will enable customers to operationalize Intel 471 intelligence easily and at near real time within their Anomali deployment and security stack.”
“Threat analysts require immediate access to RiskIQ’s unique datasets to understand and respond to the adversary,” said Lou Manousos, chief executive officer at RiskIQ. “Our integration with the Anomali Threat Platform ensures that analysts have the right information available just a click away at all times.”
Partners can learn more about the SDKs and the APP Store program and register for access at www.anomali.com/app-store. The Detect ‘18 Conference begins this morning with keynote addresses from Hugh Njemanze and General Colin L. Powell, USA (Ret.). More information available at www.anomali.com/detect18.
Anomali detects adversaries and tells you who they are. Organizations rely on the Anomali Threat Platform to detect threats, understand the adversary, and respond effectively. Anomali arms security teams with machine learning optimized threat intelligence and identifies hidden threats targeting their environments. Anomali enables organizations to collaborate and share threat information among trusted communities and is the most widely adopted platform for ISACs worldwide. To learn more, visit www.anomali.com and follow it on Twitter: @anomali.
Haylee Hewlett Sr. Marketing Manager (408) 800-4050
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
Family of Constant-Current Dimmable Buck LED Drivers18.12.2018 11:00 | Pressemelding
1.5A, 3A Buck LED Drivers Target ISO26262 automotive and industrial applications MILPITAS, Calif., Dec. 18, 2018 (GLOBE NEWSWIRE) -- AMS, the Analog Mixed-Signal division of ISSI, has introduced a family of switching buck LED Drivers for automotive and industrial applications. This family of highly integrated switching constant current buck LED Drivers are targeted for 12V/24V battery connected, space-constrained, electromagnetic (EMC) sensitive applications such as Headlight, Front and Rear Fog lights, Day time Running lights to name a few. The device family supports a wide DC voltage input range of 4.5V to 38V and outputs a 5% regulated current of 1.5A or 3A; depending on the particular device, see table. The integrated power MOSFET is configured to switch in the constant on-time mode delivering true average current. Switching at a frequency of up to 2MHz which is adjustable with an external resistor, these buck LED Drivers can use smaller output inductor and capacitor values thereby
John Charman Appointed Chief Executive Officer of Sompo Holdings Overseas Insurance Business and Nigel Frudd Appointed as Chief Executive Officer of Sompo International18.12.2018 10:13 | Pressemelding
Mr. Charman and Mr. Frudd to Join Sompo Holdings New Global Executive Committee PEMBROKE, Bermuda, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Sompo International Holdings Ltd. (Sompo International), a Bermuda-based specialty provider of property and casualty insurance and reinsurance, announced today that effective April 1, 2019, Mr. John Charman, currently Chairman of the Board of Directors and Chief Executive Officer of Sompo International, will be promoted to Chief Executive Officer of Overseas Insurance Business in Sompo Holdings, Inc. (Sompo Holdings). This segment of Sompo Holdings’ business currently represents more than 27% of Sompo Holdings Group’s adjusted profit, employing around 9,000 people in 30 countries and regions and is projected to have more than $10 billion in gross premiums by 2020. In such capacity, Mr. Charman will join the new Global Executive Committee of Sompo Holdings (Global ExCo) which will be established in April 2019 to provide expertise and input on group-wide st
LeddarTech Selects BlackBerry’s QNX Operating System for its Auto and Mobility LiDAR Platform18.12.2018 06:05 | Pressemelding
The QNX OS for Safety runs the software at the core of LeddarTech’s innovative automotive LiDAR development platform that enables the design of differentiated LiDAR solutions tailored to specific autonomous driving applications. QUEBEC CITY, Dec. 18, 2018 (GLOBE NEWSWIRE) -- LeddarTech , an industry leader providing the most versatile, scalable Auto and Mobility LiDAR Platform, today announced it has selected the QNX OS for Safety as the operating system for its LeddarSP Digital Signal Processing library. The LeddarSP software works in tandem with LeddarCore systems-on-chip to form the LeddarEngine, which is embedded at the heart of a variety of LiDAR sensor designs that enable ADAS and autonomous driving applications. “We believe that there is no safety without security,” said Grant Courville, VP of QNX Product Management and Strategy at BlackBerry. “We are thrilled to provide LeddarTech, an industry leader in LiDAR technology, with the reliable foundation necessary for building compe
Align Technology Reaches 6 Millionth Invisalign® Patient Milestone With Tween Patient From China18.12.2018 02:30 | Pressemelding
12-year old Yuzhe Wang from Beijing, China is in treatment with Invisalign trained doctor Jiawei Wo using Invisalign Comprehensive with Mandibular Advancement Accelerating adoption of Invisalign clear aligner treatment globally reflects Align’s continued investment in product innovation and commitment to international expansion BEIJING and SAN JOSE, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) today announced that over 6 million patients have begun treatment with Invisalign - the most advanced clear aligner system in the world, including 1.4 million teenage patients*. This is a significant milestone for the company and the over 150,000 Invisalign-trained doctors worldwide, reflecting accelerating adoption of Invisalign treatment by adults and teens alike. The 6 millionth Invisalign patient, Yuzhe Wang, is a 12-year-old student of the International School of Beijing, who began treatment in October 2018 using Invisalign Comprehensive with Mandibular Adv
Euronet USA’s Advanced Technology Solution Selected by Banco de Moçambique for Their National Payment Network18.12.2018 00:15 | Pressemelding
LEAWOOD, Kan., Dec. 17, 2018 (GLOBE NEWSWIRE) -- On Monday, December 10, 2018, Euronet USA, Inc. signed an agreement with Banco de Moçambique to provide a modernized national payment network solution to Mozambique. Under the agreement, Euronet will provide state-of-the-art software for the financial system in Mozambique. Euronet’s superior technology combined with over 40 years of experience in the payments landscape makes them well suited to deliver a robust solution to meet the country’s existing and future requirements. This arrangement recognizes Euronet’s leadership position in the region as this solution will be used to drive all payment processing in the country. “We are extremely honored to grow our strong relationship with the country of Mozambique, by providing advanced and scalable products and services that we deploy successfully around the world,” said Cindy Ashcraft, Vice President of Euronet Worldwide and Managing Director of Euronet Software Solutions, headquartered in
ProQR Announces Publication in Nature Medicine of QR-110 Data for Leber’s Congenital Amaurosis 1017.12.2018 17:52 | Pressemelding
LEIDEN, Netherlands and CAMBRIDGE, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases, today announced the publication of a peer-reviewed manuscript describing the previously announced interim results of a clinical trial of QR-110 for the treatment of Leber’s congenital amaurosis 10 (LCA10) in the journal Nature Medicine. “It was enormously gratifying to see robust improvements in visual acuity and significant augmentations in the patient’s ability to detect lights, and impressive to observe these effects within the first three months following a single injection,” said Professor Artur V. Cideciyan, Ph.D., who was one of the co-investigators at the Scheie Eye Institute of the University of Pennsylvania. “LCA10 is a severe form of childhood blindness and this is a major step forward in the treatment of these previously